To date, there has been no official practice guideline for the diagnosis of HBOC syndrome in Vietnam; however, available national guidelines for the treatment of breast and ovarian cancer recommend target therapy for these patients with BRCA1/2 gene mutations. Here, BRCA1 is linked to hereditary breast ovarian cancer syndrome.